NCT04691700View on ClinicalTrials.gov

GOREISAN for Heart Failure (GOREISAN-HF) Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,164

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Heart FailureEdemaTraditional Japanese MedicineKampo MedicineClinical Trial
Interventions
DRUG

Goreisan

Add Goreisan 7.5g per day to standard treatment with the intention to reduce or discontinue the existing diuretics

DRUG

Standard Treatment

Standard therapy without Goreisan

Trial Locations (1)

606-8507

RECRUITING

Kyoto University Graduate School of Medicine, Kyoto

All Listed Sponsors
lead

Takeshi Morimoto

OTHER